Johnson & Johnson Investor Conference Call on Voluntary Baby Powder Lot Recall Transcript
Good morning, and welcome to the Johnson & Johnson conference call. (Operator Instructions) This call is being recorded. If anyone has any objections, you may disconnect at this time. (Operator Instructions)
I will now like to turn the call over to Chris DelOrefice, Vice President of Investor Relations for Johnson & Johnson. Thank you. You may begin.
Great. Thank you, everyone, for taking the time to connect today. Joining me today is Kathy Wengel, Executive Vice President and Chief Global Supply Chain Officer; Dr. Susan Nicholson, Vice President of Women's Health in our medical safety organization; and Lynne Szczepaniak, Vice President, Regulatory Affairs, Consumer.
As you saw, we did issue a press release earlier today about our voluntary recall of 1 lot of Johnson's Baby Powder. Product quality and safety are important issues for us, and we know that they're important to you as well. While Johnson & Johnson is continuing to investigate the matter in cooperation with the FDA, we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |